Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BDTX Black Diamond Therapeutics, Inc.

盘前交易 04-27 05:00:23 EDT

2.97

-0.13

-4.19%

盘前3.00

+0.03+1.01%

04:30 EDT

最高3.11	最低2.88	成交量101.75万
今开3.11	昨收3.10	日振幅7.58%
总市值1.70亿	流通市值1.17亿	总股本5,729万
成交额300.33万	换手率2.59%	流通股本3,924万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BDTX","market":"US","secType":"STK","nameCN":"Black Diamond Therapeutics, Inc.","latestPrice":2.97,"timestamp":1777060800000,"preClose":3.1,"halted":0,"volume":1017511,"hourTrading":{"tag":"盘前","latestPrice":3,"preClose":2.97,"latestTime":"04:30 EDT","volume":2328,"amount":7011.4073112,"timestamp":1777278652523,"change":0.03,"changeRate":0.010101,"amplitude":0.020842},"delay":0,"changeRate":-0.0419354838709677,"floatShares":39244252,"shares":57288750,"eps":0.39,"marketStatus":"盘前交易","change":-0.13,"latestTime":"04-27 05:00:23 EDT","open":3.11,"high":3.11,"low":2.875,"amount":3003330.4415862,"amplitude":0.075806,"askPrice":2.99,"askSize":26,"bidPrice":2.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.39,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777296600000},"marketStatusCode":1,"adr":0,"listingDate":1580360400000,"exchange":"NASDAQ","adjPreClose":2.97,"preHourTrading":{"tag":"盘前","latestPrice":3,"preClose":2.97,"latestTime":"04:30 EDT","volume":2328,"amount":7011.4073112,"timestamp":1777278652523,"change":0.03,"changeRate":0.010101,"amplitude":0.020842},"postHourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":2.97,"latestTime":"19:01 EDT","volume":2726,"amount":8076.1399,"timestamp":1777071702833,"change":0.01,"changeRate":0.003367,"amplitude":0.018519},"volumeRatio":1.0137939828400206,"impliedVol":0.927,"impliedVolPercentile":0.396},"requestUrl":"/m/hq/s/BDTX","defaultTab":"news","newsList":[{"id":"1176614034","title":"Black Diamond Therapeutics公布Silevertinib一线治疗EGFRm NSCLC患者的二期临床数据将在2026年ASCO年会进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1176614034","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176614034?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:41","pubTimestamp":1776782496,"startTime":"0","endTime":"0","summary":"生物制药公司Black Diamond Therapeutics, Inc.近日宣布，其研发的Silevertinib在针对EGFR突变非小细胞肺癌（EGFRm NSCLC）患者的一线治疗二期临床试验数据，已被选入2026年美国临床肿瘤学会（ASCO）年会进行口头报告。这项重要研究成果将于全球肿瘤学专家面前亮相，标志着该疗法在临床开发进程中取得关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158984369","title":"Black Diamond Therapeutics公布2025年第四季度及全年财务业绩并更新企业动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1158984369","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158984369?lang=zh_cn&edition=full","pubTime":"2026-03-17 04:03","pubTimestamp":1773691394,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics, Inc.近日披露了其2025年第四季度及全年的财务报告，同时向市场通报了公司最新的运营进展与战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605147440","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘大幅下挫6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605147440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605147440?lang=zh_cn&edition=full","pubTime":"2026-01-21 00:19","pubTimestamp":1768925967,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日00时19分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下跌6.05%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Jaguar Health, Inc.、Rapt Therapeutics, Inc.、Corvus Pharmaceuticals, Inc.较为活跃，换手率分别为122.26%、83.97%、53.81%，振幅较大的相关个股有Corvus Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Dermata Therapeutics Inc C/Wts ，振幅分别为48.57%、48.50%、41.00%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121001927953d9620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121001927953d9620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BDTX","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603952570","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603952570?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228293,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时31分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下挫5.34%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Mereo Biopharma Group Plc、Day One Biopharmaceuticals, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为495.70%、103.78%、39.92%，振幅较大的相关个股有Zentalis Pharmaceuticals, Inc.、Novabay Pharmaceuticals, Inc.、Newcelx Ltd.，振幅分别为13.10%、10.95%、10.05%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BDTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184284519","title":"Black Diamond计划于2026年上半年启动Silevertinib在新诊断胶质母细胞瘤患者中的随机二期临床试验；预计2028年公布初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1184284519","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184284519?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:03","pubTimestamp":1764763388,"startTime":"0","endTime":"0","summary":"Black Diamond计划于2026年上半年启动Silevertinib在新诊断胶质母细胞瘤患者中的随机二期临床试验；预计2028年公布初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139569651","title":"黑钻石治疗公司申请最高达5亿美元的混合融资 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1139569651","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139569651?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:46","pubTimestamp":1763574399,"startTime":"0","endTime":"0","summary":"11月13日 - 黑钻石治疗公司（Black Diamond Therapeutics Inc）宣布，已提交申请，计划通过混合融资方式筹集最高达5亿美元的资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101646691","title":"黑钻石治药公司：Piper Sandler启动覆盖，给予增持评级；目标价9美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101646691","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101646691?lang=zh_cn&edition=full","pubTime":"2025-11-18 12:19","pubTimestamp":1763439549,"startTime":"0","endTime":"0","summary":"黑钻石治药公司：Piper Sandler启动覆盖，给予增持评级；目标价9美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208823","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208823?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:20","pubTimestamp":1741623617,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时20分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下跌5.05%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3704.52%、3188.46%、944.65%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002018a26a62fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002018a26a62fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BDTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518728166","title":"Black Diamond Therapeutics, Inc.2024财年实现净利润-69.68百万美元，同比增加15.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518728166?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536076,"startTime":"0","endTime":"0","summary":"3月10日，Black Diamond Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-69.68百万美元，同比增加15.48%；其中营业收入为0.00美元，每股基本收益为-1.27美元。从资产负债表来看，Black Diamond Therapeutics, Inc.总负债39.36百万美元，其中短期债务3.40百万美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2025年3月10日，当前有5家机构对Black Diamond Therapeutics, Inc.目标价做出预测，其中目标均价为14.00美元，其中最低目标价为9.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000237a2689875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000237a2689875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517535444","title":"Stifel：维持Black Diamond Therapeutic(BDTX.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517535444?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:52","pubTimestamp":1741366373,"startTime":"0","endTime":"0","summary":"Stifel：维持Black Diamond Therapeutic(BDTX.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08005248604792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154699655","title":"Black Diamond Therapeutics第四季度每股亏损$(0.28)，好于预期$(0.31)","url":"https://stock-news.laohu8.com/highlight/detail?id=1154699655","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154699655?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:07","pubTimestamp":1741295220,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics报告第四季度每股亏损$，好于分析师预期的$，比预期高出9.68%。与去年同期的每股亏损$相比，这一数据增长了17.65%。以上内容来自Benzinga Earnings专栏，原文如下：Black Diamond Therapeutic  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 9.68 percent. This is a 17.65 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDE","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516527406","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516527406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516527406?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:53","pubTimestamp":1741027991,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时53分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅下挫5.46%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4445.09%、200.45%、180.24%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025311abe67d69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025311abe67d69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514589023","title":"Black Diamond Therapeutics, Inc.盘中异动 临近收盘快速下挫5.85%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514589023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514589023?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:44","pubTimestamp":1740689098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时44分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅下挫5.85%。截至发稿，该股报1.93美元/股，成交量34.4847万股，换手率0.61%，振幅7.07%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1947.60%、410.74%、197.24%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280444589895540d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280444589895540d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514018409","title":"Black Diamond Therapeutics, Inc.盘中异动 急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514018409?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:46","pubTimestamp":1740494789,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时46分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅下挫5.07%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为897.80%、657.29%、535.92%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224630abdc8211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224630abdc8211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778329","title":"Black Diamond Therapeutics, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778329?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:06","pubTimestamp":1740409561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时06分，Black Diamond Therapeutics, Inc.股票出现波动，股价大幅下挫5.08%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为163.64%、71.51%、25.97%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230602962ea18a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230602962ea18a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513216972","title":"Black Diamond Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216972?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:28","pubTimestamp":1740162522,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时28分，Black Diamond Therapeutics, Inc.股票出现波动，股价急速跳水5.04%。截至发稿，该股报2.17美元/股，成交量24.4227万股，换手率0.43%，振幅7.24%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为276.68%、245.37%、136.19%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022843988e1218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022843988e1218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512199375","title":"Black Diamond Therapeutics, Inc.盘中异动 大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512199375?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:24","pubTimestamp":1739906674,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时24分，Black Diamond Therapeutics, Inc.股票出现波动，股价急速下挫5.06%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Estrella Immunopharma, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为854.53%、210.18%、169.11%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219032434a24ae8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219032434a24ae8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861319","title":"Black Diamond Therapeutics, Inc.盘中异动 急速下挫5.28%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510861319?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197959,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下挫5.28%。截至发稿，该股报2.33美元/股，成交量5.1027万股，换手率0.09%，振幅4.06%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1710.24%、866.95%、581.35%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为30.46%、26.71%、16.04%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223240abc9a54f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223240abc9a54f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509778604","title":"Black Diamond Therapeutics, Inc.盘中异动 下午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778604?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:21","pubTimestamp":1738956103,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时21分，Black Diamond Therapeutics, Inc.股票出现波动，股价大幅下跌5.16%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Nutriband Inc C/Wts 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8386.75%、180.68%、141.95%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.78%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032143961b6905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208032143961b6905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509255372","title":"Black Diamond Therapeutics, Inc.盘中异动 下午盘快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509255372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509255372?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:06","pubTimestamp":1738785980,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时06分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速上涨5.12%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.45%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Transcode Therapeutics, Inc.、Invivyd, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4662.47%、2413.22%、1769.16%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为132.24%、99.51%、87.50%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040620a23ac02e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040620a23ac02e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackdiamondtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0294},{"period":"1month","weight":0.3562},{"period":"3month","weight":0.1379},{"period":"6month","weight":-0.2443},{"period":"1year","weight":0.8447},{"period":"ytd","weight":0.2222}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Black Diamond Therapeutics, Inc.于2014年12月在特拉华州成立。该公司是一家临床阶段的肿瘤学公司，专注于开发用于治疗基因定义肿瘤患者的MasterKey疗法。该公司的目标是基因定义癌症患者中不存在药物的致癌驱动基因突变。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.139571},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.101126},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.091468},{"month":4,"riseRate":0.714286,"avgChangeRate":0.115186},{"month":5,"riseRate":0.5,"avgChangeRate":-0.050797},{"month":6,"riseRate":0.666667,"avgChangeRate":0.380267},{"month":7,"riseRate":0.5,"avgChangeRate":-0.00251},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009829},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.106486},{"month":10,"riseRate":0.5,"avgChangeRate":-0.063219},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.007717},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.108792}],"exchange":"NASDAQ","name":"Black Diamond Therapeutics, Inc.","nameEN":"Black Diamond Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Black Diamond Therapeutics, Inc.(BDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Black Diamond Therapeutics, Inc.,BDTX,Black Diamond Therapeutics, Inc.股票,Black Diamond Therapeutics, Inc.股票老虎,Black Diamond Therapeutics, Inc.股票老虎国际,Black Diamond Therapeutics, Inc.行情,Black Diamond Therapeutics, Inc.股票行情,Black Diamond Therapeutics, Inc.股价,Black Diamond Therapeutics, Inc.股市,Black Diamond Therapeutics, Inc.股票价格,Black Diamond Therapeutics, Inc.股票交易,Black Diamond Therapeutics, Inc.股票购买,Black Diamond Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Black Diamond Therapeutics, Inc.(BDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}